Cancer News
Half of Biopsies for Bladder Cancer Inadequate for Staging

Sequencing Radium-223 and Docetaxel in Prostate Cancer

European OK for Olaparib in Ovarian Cancer

Metastatic Cancer Neglected in New US Clinical Trial Group

Thyroid Cancer Genomics May Redefine Diagnosis, Treatment
New drug could help in battle against cervical cancer

Cancer drug discovery system is broken, global summit hears

The quality of biopsy is directly linked to survival in patients with bladder cancer

Research reveals how lymph nodes expand during disease

'Designer' nanodevice could improve treatment options for cancer sufferers
Health Tip: Coping With Chronic Pain

Mutations Linked to Blood Cancers Rise With Age, Study Shows

Y Chromosome Loss May Predict Earlier Death for Men

Gene May Help Shield Hispanic Women From Breast Cancer, Study Says

Healthy Lifestyle May Boost Breast Cancer Survival
Patient Profile: Liana's Looms of Love

UCLA Vice Chancellor for Research Elected to Institute of Medicine

UCLA Cancer Researcher Receives Prestigious Innovator Award for Developing New Ways to Use Blood Stem Cells to Attack Cancer

Leading-Edge Lung Cancer Treatment Advances with $1M Grant to UCLA Scientists

Melanoma Drug Combo Improves Patient Survival Rate, Decreases Risk of Harsh Side Effect
Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: A prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial

Molecular testing for selection of patients with lung cancer for epidermal growth factor receptor and anaplastic lymphoma kinase tyrosine kinase inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Guideline

Weekly rituximab consolidation following four cycles of R-CHOP induction chemotherapy in very elderly patients with diffuse large B-cell lymphoma: Consortium for improving survival of lymphoma study (CISL)

Anti-angiogenic therapy versus dose-dense paclitaxel therapy for frontline treatment of epithelial ovarian cancer: Review of phase III randomized clinical trials

Preliminary results of a phase II trial of proton radiotherapy for pediatric rhabdomyosarcoma